YS Biopharma Co., Ltd. announced that it has entered into a share purchase agreement with an institutional investor to issue 95,269,762 ordinary shares at an issue price of $0.41986 per Share for the gross proceeds of $39,999,962.27332 on February 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9071 USD | -1.28% | -4.53% | +77.51% |
21/05 | YS Biopharma Co., Ltd. Approves Board Appointments | CI |
21/05 | YS Biopharma Co., Ltd. has Changed its Name to LakeShore Biopharma Co., Ltd | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.51% | 171M | |
-2.00% | 90.27B | |
+1.32% | 40.12B | |
-15.73% | 31.75B | |
+62.61% | 26.6B | |
-21.28% | 14.41B | |
-8.50% | 12.92B | |
-44.07% | 11.3B | |
-13.06% | 11.44B | |
+4.87% | 8.87B |
- Stock Market
- Equities
- YS Stock
- News YS Biopharma Co., Ltd.
- YS Biopharma Co., Ltd. announced that it expects to receive $39.999962 million in funding